肿瘤患者肺结节的管理:AJR 专家小组叙述性综述
本文为 AJR 专家小组叙述性综述,汇总相关文献并提供专家意见,讨论肿瘤患者偶然发现或筛查检出肺结节的管理。已治疗肺癌患者的新结节最可能为远处转移或第二原发肺癌,CT 特征如大小和成分应指导活检、PET/CT 和 CT 随访决策;肺外肿瘤患者的结节管理需个体化风险评估。
要点
- 已治疗肺癌患者新发结节最可能为远处转移或第二原发肺癌,结节大小和成分等 CT 特征应指导后续处理决策。
- 肺外肿瘤患者的结节管理需个体化风险评估:吸烟与原发性肺癌风险升高相关,特定原发癌类型与肺转移风险升高相关。
- 非肿瘤性病因如感染、药物毒性及放疗后或术后改变也应纳入考虑。
核心结论
- 已治疗肺癌患者的新发结节最可能代表原发肺癌的远处转移或第二原发肺癌,CT 特征如结节大小和成分应指导活检、PET/CT 和 CT 随访的决策。
- 肺外肿瘤患者的结节管理需要个体化风险评估,吸烟与原发性肺癌风险升高相关,特定原发癌类型与肺转移风险升高相关。
- 感染、药物毒性以及放疗后或术后改变等非肿瘤性病因也应考虑。
- 需要未来前瞻性研究提供循证数据以协助该情境下的临床决策。
研究设计与样本
- 本文为 AJR 专家小组叙述性综述,汇总相关文献并提供专家意见。
- 当前肺癌筛查指南推荐对高危个体(包括有癌症病史且符合吸烟史条件者)行低剂量胸部 CT。
- 大型肺癌筛查试验对癌症生存者的纳入不一致,且很少有研究评估该人群的肺结节管理。
关键影像表现/征象
- 已治疗肺癌患者的新发结节最可能为原发肺癌的远处转移或第二原发肺癌。
- CT 特征如结节大小和成分应指导活检、PET/CT 和 CT 随访的决策。
- 肺外肿瘤患者的结节需考虑原发肺癌与肺转移的鉴别,吸烟与原发性肺癌风险升高相关,特定原发癌类型与肺转移风险升高相关。
- 非肿瘤性病因如感染、药物毒性及放疗后或术后改变也应考虑。
临床应用与阅片要点
- 对已治疗肺癌患者的新发结节,依据结节大小和成分等 CT 特征决策活检、PET/CT 和 CT 随访。
- 对肺外肿瘤患者的结节行个体化风险评估,结合吸烟史和原发癌类型判断原发性肺癌与肺转移的可能性。
- 阅片时也应考虑感染、药物毒性及放疗后或术后改变等非肿瘤性病因。
局限性
- 大型肺癌筛查试验对癌症生存者的纳入不一致。
- 很少有研究评估该人群中肺结节的管理。
- 需要未来前瞻性研究提供循证数据以协助该情境下的临床决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Cancer survivors are at higher risk than the general population for development of a new primary malignancy, most commonly lung cancer. Current lung cancer screening guidelines recommend low-dose chest CT for high-risk individuals, including patients with a history of cancer and a qualifying smoking history. However, major lung cancer screening trials have inconsistently included cancer survivors, and few studies have assessed management of lung nodules in this population. This narrative review highlights relevant literature and provides expert opinion for management of pulmonary nodules detected incidentally or by screening in oncologic patients. In patients with previously treated lung cancer, a new nodule most likely represents distant metastasis from the initial lung cancer or a second primary lung cancer; CT features such as nodule size and composition should guide decisions regarding biopsy, PET/CT, and CT surveillance. In patients with extrapulmonary cancers, nodule management requires individualized risk assessment; smoking is associated with increased odds of primary lung cancer, whereas specific primary cancer types are associated with increased odds of pulmonary metastasis. Nonneoplastic causes, such as infection, medication toxicity, and postradiation or postsurgical change, should also be considered. Future prospective studies are warranted to provide evidence-based data to assist clinical decision-making in this context.
引用
- Araujo-Filho JAB, Halpenny D, McQuade C, et al. Management of Pulmonary Nodules in Oncologic Patients: AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2020. PMID: 33355489. doi:10.2214/AJR.20.24907
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。